UA128597U - METHOD OF TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS - Google Patents

METHOD OF TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS

Info

Publication number
UA128597U
UA128597U UAU201803635U UAU201803635U UA128597U UA 128597 U UA128597 U UA 128597U UA U201803635 U UAU201803635 U UA U201803635U UA U201803635 U UAU201803635 U UA U201803635U UA 128597 U UA128597 U UA 128597U
Authority
UA
Ukraine
Prior art keywords
treatment
brain disorders
cerebrovascular
cerebrovascular brain
cell preparation
Prior art date
Application number
UAU201803635U
Other languages
Ukrainian (uk)
Inventor
Владислав Георгієвич Бабійчук
Вікторія Сергіївна Айдарова
Ольга Валентинівна Кудокоцева
Іван Іванович Ломакін
Вячеслав Володимирович Мамонтов
Original Assignee
Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України filed Critical Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Priority to UAU201803635U priority Critical patent/UA128597U/en
Publication of UA128597U publication Critical patent/UA128597U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Спосіб лікування цереброваскулярних порушень головного мозку передбачає використання клітинного препарату. Як клітинний препарат використовують кріоконсервовані ядровмісні клітини кордової крові людини, які вводять одноразово внутрішньочеревно, в дозі (1,0-2,0)×107/кг.A method of treating cerebrovascular disorders of the brain involves the use of a cell preparation. As a cell preparation, cryopreserved nucleated human cord blood cells, which are administered intraperitoneally at a dose of (1.0-2.0) × 107 / kg, are used.

UAU201803635U 2018-04-05 2018-04-05 METHOD OF TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS UA128597U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201803635U UA128597U (en) 2018-04-05 2018-04-05 METHOD OF TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201803635U UA128597U (en) 2018-04-05 2018-04-05 METHOD OF TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS

Publications (1)

Publication Number Publication Date
UA128597U true UA128597U (en) 2018-09-25

Family

ID=63709607

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201803635U UA128597U (en) 2018-04-05 2018-04-05 METHOD OF TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS

Country Status (1)

Country Link
UA (1) UA128597U (en)

Similar Documents

Publication Publication Date Title
SA518391624B1 (en) Modulators of ROR-GAMMA
SA518392101B1 (en) Benzimidazole Derivatives as Modulators of ROR-GAMMA
EA201890725A1 (en) PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION
MX2017013562A (en) Microbiome regulators and related uses thereof.
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
EA201891152A1 (en) EXTRACELLULAR VESICULES OF NERVOUS CELLS
PE20190338A1 (en) METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
MX2020010369A (en) Implantable particles and related methods.
CO2017000346A2 (en) Aβ protofibril binding antibodies
EA201990400A1 (en) COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION
MX2018010508A (en) Improved preparations of adult liver progenitor cells.
MX2022009736A (en) P2X<sub>3</sub> AND/OR P2X<sub>2/3</sub> COMPOUNDS AND METHODS.
EA201891007A1 (en) AIMING FOR FORMILPEPTID RECEPTOR 2 / LIPOXIN A RECEPTOR (FPR2 / ALX) FOR TREATING HEART DISEASES
EA201890442A1 (en) OBTAINING PHOTORECEPTORS FOR THE TREATMENT OF RETITAL DISEASES
MX2020005640A (en) Humanized anti-liv1 antibodies for the treatment of breast cancer.
JOP20220092A1 (en) Anti-beta-amyloid antibody for treating alzheimer's disease
CR20220216A (en) Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
EA201891710A1 (en) THERAPEUTIC CONNECTIONS
MX2023010711A (en) Phenalkylamines and methods of making and using the same.
MX2018002816A (en) Methods of treating multiple myeloma and plasma cell leukemia by t cell therapy.
MX2020010667A (en) Prodrugs of deoxynucleosides for treatment of diseases cased by unbalanced nucleotide pools.
MX2021007687A (en) Novel salts of selective estrogen receptor degraders.
UA128597U (en) METHOD OF TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS